Jochen Abel
About Jochen Abel
Jochen Abel is a Senior Pricing Manager at Bristol Myers Squibb in München, Bayern, Deutschland, with over 9 years of experience at the company and a strong academic background in biochemistry and molecular biology.
Current Role as Senior Pricing Manager
Jochen Abel currently holds the position of Senior Pricing Manager at Bristol Myers Squibb in München, Bayern, Deutschland. In this role, Jochen is responsible for overseeing pricing strategies and ensuring competitive positioning within the market. His extensive experience in pricing and market access makes him a valuable asset to the company.
Previous Roles at Bristol Myers Squibb
Before becoming Senior Pricing Manager, Jochen Abel served as SHI Contracting Specialist at Bristol Myers Squibb in München und Umgebung, Deutschland, from 2017 to 2020. Prior to that, he held the role of Access Manager from 2014 to 2017. These roles contributed to his comprehensive understanding of market dynamics and contract negotiations within the pharmaceutical industry.
Experience at Gilead Sciences
Jochen Abel began his career in the pharmaceutical industry at Gilead Sciences as a Manager Market Access in 2014 for 7 months. In this role, he was involved in market strategy and access planning, gaining critical insights into the entry barriers and opportunities in the industry.
Consultant Role at BiPRO GmbH
Jochen Abel worked as a Consultant at BiPRO GmbH in New York, New York, United States, for 2 years, from 2011 to 2013. This position allowed him to develop expertise in consultancy services, focusing on providing strategic advice and solutions within the clinical and biochemical domains.
Educational Background in Biochemistry and Molecular Biology
Jochen Abel has a strong academic foundation in biochemistry and molecular biology. He earned his Doctor of Philosophy (Ph.D.) from Ludwig-Maximilians Universität München, where he studied from 2006 to 2011. Additionally, he achieved a Diplom in Biochemie from the University of Regensburg, studying there from 2000 to 2006. He also spent 11 months at the University of Technology, Sydney, furthering his studies in biochemistry.